abrdn Healthcare Investors (NYSE:HQH – Get Free Report) was the target of a significant drop in short interest in January. As of January 30th, there was short interest totaling 41,483 shares, a drop of 20.4% from the January 15th total of 52,128 shares. Approximately 0.1% of the shares of the stock are sold short. Based on an average daily trading volume, of 207,363 shares, the days-to-cover ratio is presently 0.2 days. Based on an average daily trading volume, of 207,363 shares, the days-to-cover ratio is presently 0.2 days. Approximately 0.1% of the shares of the stock are sold short.
abrdn Healthcare Investors Trading Up 1.4%
Shares of NYSE:HQH traded up $0.27 during trading on Friday, reaching $19.86. The stock had a trading volume of 230,240 shares, compared to its average volume of 179,093. The firm’s fifty day moving average is $19.14 and its 200 day moving average is $18.23. abrdn Healthcare Investors has a 52 week low of $13.77 and a 52 week high of $19.89.
abrdn Healthcare Investors Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Friday, February 20th will be issued a dividend of $0.63 per share. This represents a $2.52 annualized dividend and a yield of 12.7%. This is a boost from abrdn Healthcare Investors’s previous quarterly dividend of $0.57. The ex-dividend date is Friday, February 20th.
Institutional Inflows and Outflows
abrdn Healthcare Investors Company Profile
abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.
The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.
Featured Stories
- Five stocks we like better than abrdn Healthcare Investors
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
